Related Experiment Videos
Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans
Antimicrobial Agents and Chemotherapy
|January 1, 1981
Abstract:
The combination of amphotericin B and rifampin was synergistic in vitro in both inhibiting and killing seven strains of Cryptococcus neoformans by the checkerboard microtitration technique.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Imiquimod for the treatment of genital warts: a quantitative systematic review.
BMC infectious diseases·2001
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
The relationship between intramuscular temperature, skin temperature, and adipose thickness during cryotherapy and rewarming.
Archives of physical medicine and rehabilitation·2001
Effect of knee joint effusion on quadriceps and soleus motoneuron pool excitability.
Medicine and science in sports and exercise·2001
Pathogenesis I: interactions of host cells and fungi.
Medical mycology·2001
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients.
Antimicrobial agents and chemotherapy·2026
XAB06, a glyco-humanized broad-spectrum anti-Pseudomonas aeruginosa polyclonal antibody, protects mice in a lethal sepsis model.
Antimicrobial agents and chemotherapy·2026
In vitro activity profiles and temporal trends in reduced susceptibility to azoles in Coccidioides in the United States.
Antimicrobial agents and chemotherapy·2026
Revisiting rhinoscleroma microbiology: a case with concordant dual-specimen bacterial isolation.
Frontiers in cellular and infection microbiology·2026
Salivary Extracellular Vesicles from Host, Bacteria and Fungus as Nanomessengers Reflecting Host-Microbiome Interaction in Periodontal Inflammation.
ACS applied materials & interfaces·2026
Benchmarking computational decontamination of ambient RNA.
Frontiers in bioinformatics·2026